Clinical Trial Update: Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia [Phase 2]

View source ↗

Summary

Phase 2 study assessing Stemchymal® for efficacy and safety in cerebellar ataxia has completed

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebellar Ataxia

Drugs mentioned

• Stemchymal

Snippet

Sponsor: Steminent Biotherapeutics Inc. | Conditions: Cerebellar Ataxia | Phase 2 | Status: COMPLETED